Searched for
NEW DRUGS AND CLINICAL TRIALS RULES 2019
Lord’s Mark Industries reports ₹82 Crore H1 profit; plans AI healthcare product launches in 2027Lord's Mark Industries Ltd has reported a consolidated net profit of ₹82.01 crore during the first half of FY27, with revenue hitting ₹718....
US stocks: Summit shares drop after US FDA declines to approve lung cancer drugSummit Therapeutics faced a notable decline in share value following the FDA's ruling on ivonescimab, which revealed insufficient overall s...
NPS rules change from December 1: What subscribers need to know about choosing pension schemesThe Pension Fund Regulatory and Development Authority (PFRDA) has amended the framework for classifying and presenting schemes under the Na...
Fewer than 10 people, under a year old: Anthropic reportedly paid $400 million for this biotech AI startup; what does it do?In its October announcement, the company mentioned Claude for Life Sciences, which is a tool that aims to help scientific researchers make ...
‘A man in a leather jacket who treated employees like human beings’: Nvidia VP recalls how Jensen Huang went out of his way to help him fight ‘nasty’ cancer, winning hearts onlineJohn Zedlewski, an Nvidia executive, detailed his struggle with cancer and Jensen Huang's support during that time. After Zedlewski informe...
India may open doors to multinational pharma firms for first-in-human Phase I trialsIndia is considering modifications to its pharmaceutical regulatory framework to attract multinational companies for clinical trials. Discu...
Dario Amodei says AI could make cancer, Alzheimer’s ‘relics of the past’ in less than a decade as Anthropic expands AI-driven drug discovery pushAnthropic is collaborating with several pharmaceutical companies to utilize AI in drug development processes. These partnerships aim to imp...
GLP-1 drugs for weight loss Ozempic, Wegovy linked to vision loss: What is NAION, who is at risk and what symptoms should users watch for?Side effects of weight loss drugs: The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label abou...
Does eating late really slow your metabolism? The clue came while people sleptIn a small 2026 trial, eight men ate the same meals on two different schedules. Eating late made no clear difference to how many calories t...
US FDA adds rare vision-loss warning to popular GLP-1 drugsThe US FDA will add a warning about a rare eye condition that can cause permanent vision loss to the labels of all GLP-1 drugs, including O...
Ozempic Zepbound eye risk warnings: Diabetes, weight-loss drugs Novo Nordisk's Ozempic, Wegovy, Eli Lilly's Mounjaro, Zepbound pose potential threat to eye, sudden vision loss, warns US FDAEli Lilly's Mounjaro and Zepbound and Novo Nordisk's Ozempic and Wegovy were under scanner of United States Food and Drug Administration (U...
Scientists gave mice an existing asthma drug before exposing them to peanut extract; 95% were protected from severe allergic reactions in the experimentResearchers at Northwestern University found that the asthma drug Zileuton reduces allergic reactions in mice fed peanut extract. The study...
Arunoday Singh-headed O-Health secures strategic fundingO-Health has received strategic funding from several investors to advance its healthcare technology solutions. The company aims to enhance ...
Sirolimus-coated balloon shows 8-percentage-point advantage in three-year peripheral artery trialPatients treated with sirolimus-coated balloons were more likely to remain free from repeat procedures to reopen blocked leg arteries than ...
With most drug candidates failing in humans, India’s draft rules bet on the wrong science in animal lab testingRecent draft rules in India threaten advancements in non-animal testing for drug development and safety. The new regulations may prioritize...
India leads on non-animal testing and its draft lab animal rules threaten to undo thatIndia's draft Prevention of Cruelty to Animals Rules 2026 proposes significant changes to animal research regulations and oversight. It all...
AI halves drug discovery times, but =trial bottleneck remains a costly realityNovo Nordisk, Sanofi and Dr Reddy’s Laboratories are among the companies exploring applications ranging from drug discovery to laboratory a...